Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Beta Bionics (BBNX) FCF Margin (2024 - 2025)

Historic FCF Margin for Beta Bionics (BBNX) over the last 2 years, with Q3 2025 value amounting to 36.73%.

  • Beta Bionics' FCF Margin rose 320500.0% to 36.73% in Q3 2025 from the same period last year, while for Sep 2025 it was 68.34%, marking a year-over-year increase of 140800.0%. This contributed to the annual value of 79.34% for FY2024, which is 1945000.0% up from last year.
  • Latest data reveals that Beta Bionics reported FCF Margin of 36.73% as of Q3 2025, which was up 320500.0% from 64.58% recorded in Q2 2025.
  • In the past 5 years, Beta Bionics' FCF Margin registered a high of 36.73% during Q3 2025, and its lowest value of 117.21% during Q1 2025.